Company Brainstorm Cell Therapeutics Inc.
Equities
BCLI
US10501E2019
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5169 USD | -3.80% | -8.84% | +89.34% |
Business Summary
Number of employees: 29
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chaim Lebovits
CEO | Chief Executive Officer | 53 | 07-06-30 |
Alla Patlis
DFI | Director of Finance/CFO | 37 | 12-12-22 |
Chief Tech/Sci/R&D Officer | - | 22-05-11 | |
Bob Dagher
CTO | Chief Tech/Sci/R&D Officer | 55 | 23-07-16 |
Yael Gothelf
CTO | Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 20-05-31 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
General Counsel | - | 22-05-11 | |
Mary Kay Turner
LAW | General Counsel | - | 17-08-06 |
Yossef Levy
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Irit Arbel
FOU | Founder | 64 | 00-09-21 |
Uri Yablonka
BRD | Director/Board Member | 47 | 14-06-05 |
Jacob Frenkel
CHM | Chairman | 81 | 20-03-29 |
Director/Board Member | 63 | 21-10-27 | |
Director/Board Member | 61 | 18-02-04 | |
Stacy Lindborg
BRD | Director/Board Member | 53 | 20-05-31 |
Nir Naor
BRD | Director/Board Member | 49 | 23-06-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,080,523 | 60,766,674 ( 86.71 %) | 0 | 86.71 % |
Company contact information
Brainstorm Cell Therapeutics, Inc.
1325 Avenue of Americas 28th floor
10019, New York
+201 488 0460
http://www.brainstorm-cell.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.34% | 36.72M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- BCLI Stock
- Company Brainstorm Cell Therapeutics Inc.